NASDAQ:SRTS - Sensus Healthcare Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sensus Healthcare Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.64 +0.02 (+0.43 %) (As of 02/18/2020 06:00 AM ET) Add Compare Today's Range$4.55Now: $4.64▼$4.9050-Day Range$3.50MA: $4.14▼$4.7152-Week Range$3.31Now: $4.64▼$9.23Volume137,760 shsAverage Volume29,245 shsMarket Capitalization$76.56 millionP/E RatioN/ADividend YieldN/ABeta-0.66 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Sensus Healthcare, Inc manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SRTS Previous Symbol CUSIPN/A CIK1494891 Webhttp://www.sensushealthcare.com/ Phone561-922-5808Debt Debt-to-Equity Ratio0.04 Current Ratio5.01 Quick Ratio4.66Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio464.00 P/E GrowthN/A Sales & Book Value Annual Sales$27.26 million Price / Sales2.81 Cash FlowN/A Price / Cash FlowN/A Book Value$1.64 per share Price / Book2.83Profitability EPS (Most Recent Fiscal Year)($0.10) Net Income$-1,700,000.00 Net Margins-6.24% Return on Equity-6.27% Return on Assets-4.84%Miscellaneous Employees48 Outstanding Shares16,500,000Market Cap$76.56 million Next Earnings Date5/14/2020 (Estimated) OptionableNot Optionable Receive SRTS News and Ratings via Email Sign-up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:SRTS Rates by TradingView Sensus Healthcare (NASDAQ:SRTS) Frequently Asked Questions What is Sensus Healthcare's stock symbol? Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS." How were Sensus Healthcare's earnings last quarter? Sensus Healthcare Inc (NASDAQ:SRTS) announced its quarterly earnings data on Thursday, February, 13th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.03 by $0.03. The business earned $8.51 million during the quarter, compared to the consensus estimate of $8.45 million. Sensus Healthcare had a negative net margin of 6.24% and a negative return on equity of 6.27%. View Sensus Healthcare's Earnings History. When is Sensus Healthcare's next earnings date? Sensus Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, May 14th 2020. View Earnings Estimates for Sensus Healthcare. What price target have analysts set for SRTS? 5 analysts have issued 1 year price targets for Sensus Healthcare's shares. Their forecasts range from $5.50 to $11.00. On average, they anticipate Sensus Healthcare's stock price to reach $7.63 in the next twelve months. This suggests a possible upside of 64.3% from the stock's current price. View Analyst Price Targets for Sensus Healthcare. What is the consensus analysts' recommendation for Sensus Healthcare? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sensus Healthcare. What are Wall Street analysts saying about Sensus Healthcare stock? Here are some recent quotes from research analysts about Sensus Healthcare stock: 1. HC Wainwright analysts commented, "Our price target is derived from an EV-to-sales multiple of 6.0x and TTM revenue ($1.57/share). Risks include, but are not limited to: (1) failure of SRT and IORT systems to achieve commercial success due to reimbursement, penetration rate, and/or competition; (2) failure of other potential pipeline products; and (3) potential dilution risk. Sensus Healthcare, Inc. May 13, 2019 H.C. WAINWRIGHT & CO." (5/13/2019) 2. Maxim Group analysts commented, "Sensus reported lower-than-expected 1Q19 revenue and a wider-than- expected GAAP EPS loss due to a delayed shipment of seven SRT-100 Vision systems to its largest customer. We are slightly reducing our estimates to reflect the miss and a lower 2019 growth rate." (5/10/2019) Has Sensus Healthcare been receiving favorable news coverage? Media coverage about SRTS stock has trended very negative this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sensus Healthcare earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Sensus Healthcare. Are investors shorting Sensus Healthcare? Sensus Healthcare saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 141,300 shares, an increase of 31.7% from the January 15th total of 107,300 shares. Based on an average daily trading volume, of 30,600 shares, the short-interest ratio is currently 4.6 days. Currently, 1.2% of the company's stock are short sold. View Sensus Healthcare's Current Options Chain. Who are some of Sensus Healthcare's key competitors? Some companies that are related to Sensus Healthcare include Iradimed (IRMD), SeaSpine (SPNE), Apyx Medical (APYX), Westaim (WEDXF), GenMark Diagnostics (GNMK), Repro Med Systems (KRMD), Repro-Med Systems (REPR), iCAD (ICAD), Venus Concept (VERO), Vapotherm (VAPO), Soliton (SOLY), RenovaCare (RCAR), TELA Bio (TELA), Pulse Biosciences (PLSE) and Cytosorbents (CTSO). What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Zynerba Pharmaceuticals (ZYNE), Ring Energy (REI), Ring Energy (REI), Viking Therapeutics (VKTX), Agile Therapeutics (AGRX), Inovio Pharmaceuticals (INO), Melinta Therapeutics (MLNT), Nabriva Therapeutics (NBRV), Selecta Biosciences (SELB) and Sangamo Therapeutics (SGMO). Who are Sensus Healthcare's key executives? Sensus Healthcare's management team includes the folowing people: Mr. Joseph C. Sardano, Chairman, CEO & Pres (Age 66)Mr. Arthur R. Levine, Chief Financial Officer (Age 61)Mr. Kalman Fishman, COO & CTO (Age 48)Dr. Ziv Karni, Chief Scientific Officer (Age 74)Mr. Michael Sardano, VP, Gen. Counsel, Corp. Sec. and Director of Governance & Regulatory (Age 30) When did Sensus Healthcare IPO? (SRTS) raised $20 million in an initial public offering (IPO) on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. Who are Sensus Healthcare's major shareholders? Sensus Healthcare's stock is owned by many different of retail and institutional investors. Top institutional investors include Perkins Capital Management Inc. (1.44%), Perritt Capital Management Inc. (0.68%), Garrison Bradford & Associates Inc. (0.37%), Essex Investment Management Co. LLC (0.28%), Mairs & Power INC (0.08%) and Virtu Financial LLC (0.06%). Company insiders that own Sensus Healthcare stock include Arthur Levine, Joseph C Sardano, Kalman Fishman, Richard Golin and Stephen Brad Cohen. View Institutional Ownership Trends for Sensus Healthcare. Which institutional investors are selling Sensus Healthcare stock? SRTS stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., Essex Investment Management Co. LLC and Perritt Capital Management Inc.. Company insiders that have sold Sensus Healthcare company stock in the last year include Kalman Fishman, Richard Golin and Stephen Brad Cohen. View Insider Buying and Selling for Sensus Healthcare. Which institutional investors are buying Sensus Healthcare stock? SRTS stock was bought by a variety of institutional investors in the last quarter, including Mairs & Power INC, Virtu Financial LLC, Tower Research Capital LLC TRC and Garrison Bradford & Associates Inc.. View Insider Buying and Selling for Sensus Healthcare. How do I buy shares of Sensus Healthcare? Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Sensus Healthcare's stock price today? One share of SRTS stock can currently be purchased for approximately $4.64. How big of a company is Sensus Healthcare? Sensus Healthcare has a market capitalization of $76.56 million and generates $27.26 million in revenue each year. The company earns $-1,700,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. Sensus Healthcare employs 48 workers across the globe.View Additional Information About Sensus Healthcare. What is Sensus Healthcare's official website? The official website for Sensus Healthcare is http://www.sensushealthcare.com/. How can I contact Sensus Healthcare? Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at 561-922-5808 or via email at [email protected] MarketBeat Community Rating for Sensus Healthcare (NASDAQ SRTS)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 139 (Vote Outperform)Underperform Votes: 128 (Vote Underperform)Total Votes: 267MarketBeat's community ratings are surveys of what our community members think about Sensus Healthcare and other stocks. Vote "Outperform" if you believe SRTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRTS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2020 by MarketBeat.com StaffFeatured Article: How can investors invest in the S&P/TSX Index?
